Nivolumab 100mg/10ml solution for infusion vials
NHS hospitals in England used £15,418,149 of indicative cost of Nivolumab 100mg/10ml solution for infusion vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 33.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Nivolumab 100mg/10ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Nivolumab 100mg/10ml solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| United Lincolnshire Hospitals Nhs Trust | £2,719,463 |
| Maidstone And Tunbridge Wells Nhs Trust | £2,255,213 |
| The Royal Marsden Nhs Foundation Trust | £2,214,843 |
| University Hpls Coventry & Warwick Trust | £597,865 |
| Northumbria H/Care Nhs Foundation Trust | £515,590 |
| Southend Univ Hosp Nhs Foundation Trust | £514,493 |
| Royal Cornwall Hospitals Nhs Trust | £413,635 |
| Northern Lincolnshire & Goole Nhs Ft | £346,652 |
| Norfolk & Norwich University Hpl Nhs Trt | £334,585 |
| Cambridge Univ Hosp Nhs Foundation Trust | £326,906 |
The primary-care picture
Nivolumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Nivolumab medicine page.